What amount sold does Adtech Pharma, Inc. report in Form D filings?

The latest linked filings report $3M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Adtech Pharma, Inc.'s most recent SEC filing?

Adtech Pharma, Inc.'s most recent Form D filing was on 2022-04-12.

How many investors does Adtech Pharma, Inc. have?

The most recent Form D filing lists 12 investor(s).

What type of securities does Adtech Pharma, Inc. offer?

Adtech Pharma, Inc.'s SEC Form D filings indicate equity offerings.

Adtech Pharma, Inc.

CIK: 0001892920·Pharmaceuticals·WARWICK, RI·Corporation·Founded 2020

Reported Sold

$2,982,000

Total Filings

Identified Offerings

Last Filed

Apr 12, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Apr 12, 2022Form D — New notice

Reported sold: $1,105,000 · Target: $2,000,000

Rule 506(b)·12 investors

Nov 9, 2021Form D — New notice

Reported sold: $1,877,000 · Target: $3,575,000

Rule 506(b)·19 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

$298,200

Amendment Rate

Latest reported sold across 2 identified offerings

$2,982,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Robert Kupper

Related Person

Appears on 2 filings

Lex Adjei

Related Person

Appears on 2 filings

Iok Pang

Related Person

Appears on 2 filings

Jodi Brichan

Related Person

Appears on 2 filings

Ping Wu Chang

Related Person

Appears on 1 filing

Ping Chang

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 12, 2022	New	$2,000,000	$1,105,000	12
Nov 9, 2021	New	$3,575,000	$1,877,000	19

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026